Liv Jorunn Mundal

  • Postdoc; MD
  • + 47 932 68 387

Specialist in Cardiology and Internal Medicine, Master in Health Administration; MHA, PhD

Postdoc research project:
Exploring cardiovascular disease in familial hypercholesterolemia (FH)

 

Publications 2021

Mundal LJ, Igland J, Leren TP, Retterstol K (2021)
Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study
Eur. J. Vasc. Endovasc. Surg., 61 (4), 712-713
DOI 10.1016/j.ejvs.2020.12.019

Svendsen K, Krogh HW, Igland J, Tell GS, Mundal LJ, Holven KB, Bogsrud MP, Leren TP, Retterstol K (2021)
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia
Atherosclerosis, 319, 28-34
DOI 10.1016/j.atherosclerosis.2020.12.019

Publications 2019

Bogsrud MP, Graesdal A, Johansen D, Langslet G, Hovland A, Arnesen KE, Mundal LJ, Retterstol K, Wium C, Holven KB (2019)
LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia
J. Clin. Lipidol., 13 (2), 279-286
DOI 10.1016/j.jacl.2019.01.010

Hovland A, Mundal LJ, Igland J, Veierod MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstol K (2019)
Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia: A Register Study From Norway
Stroke, 50 (1), 172-174
DOI 10.1161/STROKEAHA.118.023456

Krogh HW, Svendsen K, Igland J, Mundal LJ, Holven KB, Bogsrud MP, Leren TP, Retterstol K (2019)
Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
Sci Rep, 9, 19273
DOI 10.1038/s41598-019-55682-x

Mundal LJ, Hovland A, Igland J, Veierod MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstol K (2019)
Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia
JAMA Cardiol., 4 (11), 1156-1159
DOI 10.1001/jamacardio.2019.3903

Wisloff T, Mundal LJ, Retterstol K, Igland J, Kristiansen IS (2019)
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
Atherosclerosis, 287, 140-146
DOI 10.1016/j.atherosclerosis.2019.06.900

Publications 2018

Mundal LJ, Igland J, Veierod MB, Holven KB, Ose L, Selmer RM, Wisloff T, Kristiansen IS, Tell GS, Leren TP, Retterstol K (2018)
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-+
DOI 10.1136/heartjnl-2017-312706

Publications 2017

Hovland A, Mundal LJ, Igland J, Veierod MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstol K (2017)
Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia
Atherosclerosis, 266, 69-73
DOI 10.1016/j.atherosclerosis.2017.09.027

Lovlien M, Mundal L, Hall-Lord ML (2017)
Health-related quality of life, sense of coherence and leisure-time physical activity in women after an acute myocardial infarction
J. Clin. Nurs., 26 (7-8), 975-982
DOI 10.1111/jocn.13411

Mundal L, Igland J, Ose L, Holven KB, Veierod MB, Leren TP, Retterstol K (2017)
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur. J. Prev. Cardiol., 24 (2), 137-144
DOI 10.1177/2047487316676135

Publications 2016

Krogh HW, Mundal L, Holven KB, Retterstol K (2016)
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Eur. Heart J., 37 (17), 1398-1405
DOI 10.1093/eurheartj/ehv602

Mundal L, Retterstol K (2016)
A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries
Curr. Opin. Lipidology, 27 (4), 388-397
DOI 10.1097/MOL.0000000000000300

Mundal L, Veierod MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstol K (2016)
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur. J. Prev. Cardiol., 23 (18), 1962-1969
DOI 10.1177/2047487316666371

Publications 2015

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierod MB, Leren TP, Retterstol K (2015)
Increased mortality in familial hypercholesterolemia
Tidsskr. Nor. Laegeforen., 135 (11), 1024-1025
DOI 10.4045/tidsskr.15.0244

Publications 2014

Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierod MB, Leren TP, Retterstol K (2014)
Mortality Among Patients With Familial Hypercholesterolemia: A Registry-Based Study in Norway, 1992-2010
J. Am. Heart Assoc., 3 (6), e001236
DOI 10.1161/JAHA.114.001236